poltechdtpa 13.25mg/vial powder for injection
national centre for nuclear research (0000009483) andrzeja soltana str. 7, otwock, 05-400 - sodium diethylenetriamine pentaacetate monohydrate - powder for injection - 13.25mg/vial - sodium diethylenetriamine pentaacetate monohydrate (8000004678) 13,25mg - technetium (99mtc) pentetic acid
excenel 4g powder for solution for injection
pfizer hellas ae (0000003442) 243 messoghion avenue, neo psychiko, athens, 15451 - ceftiofur sodium; ceftiofur sodium - powder for solution for injection - 4g - ceftiofur sodium (8000001292) 4.2g; ceftiofur sodium (8000001292) 1.06g - ceftiofur (for systemic use)
zoledronic acid for injection concentrate solution
dr reddy's laboratories ltd - acide zolédronique (acide zolédronique monohydraté) - solution - 4mg - acide zolédronique (acide zolédronique monohydraté) 4mg - bone resorption inhibitors
zoledronic acid for injection solution
marcan pharmaceuticals inc - acide zolédronique (acide zolédronique monohydraté) - solution - 4mg - acide zolédronique (acide zolédronique monohydraté) 4mg - bone resorption inhibitors
zoledronic acid for injection solution
teva canada limited - acide zolédronique (acide zolédronique monohydraté) - solution - 4mg - acide zolédronique (acide zolédronique monohydraté) 4mg - bone resorption inhibitors
zoledronic acid for injection concentrate solution
omega laboratories limited - acide zolédronique (acide zolédronique monohydraté) - solution - 4mg - acide zolédronique (acide zolédronique monohydraté) 4mg - bone resorption inhibitors
zoledronic acid for injection solution
pfizer canada ulc - acide zolédronique (acide zolédronique monohydraté) - solution - 4mg - acide zolédronique (acide zolédronique monohydraté) 4mg - bone resorption inhibitors
sodium chloride 0.9 % intravenous infusion bp
teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.
sodium chloride 0.9 % intravenous infusion bp
teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 0.9 %w/v - sodium chloride - sodium chloride - treatment of isotonic extracellular dehydration. treatment of sodium depletion. vehicle or diluent of compatible drugs for parenteral administration.
baxter heparin sodium 2000iu 1000ml injection ahb0944a
baxter healthcare pty ltd - heparin sodium, quantity: 2000 iu/l - injection, solution - excipient ingredients: water for injections; sodium chloride; citric acid monohydrate; dibasic sodium phosphate dodecahydrate - indications as at 11 july 2003: heparin sodium in 0.9% sodium chloride intravenous infusion is indicated as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.